CRISPR-based genome editing has considerable therapeutic potential in a wide range of diseases 1,2,3,4,5. A key challenge is achieving efficient, clinically suitable delivery of genome editing ...
Companies have been forced to change their corporate cultures and their standards of operation. The change has been forced on them by globalization of markets and competition, growth of immediate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback